Yan, Q. and Liu, J. (2020) “Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.287052.